It’s Not You, It’s SOSA: A Case Study on Breaking Up With an FDA-Cleared Susceptibility Testing System’s Oxacillin Results for Staphylococcus spp. Other Than S. aureus and S. lugdunensis
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac421
Abstract: Abstract Background In 2021, the Clinical and Laboratory Standards Institute revised its susceptible oxacillin minimum inhibitory concentration (MIC) breakpoint for Staphylococcus spp. other than S. aureus and S. lugdunensis (SOSA) from ≤0.25 to ≤0.5 µg/mL. Here,… read more here.
Keywords: pbp2a testing; aureus lugdunensis; staphylococcus spp; cefoxitin ... See more keywords